missing translation for 'onlineSavingsMsg'
Få mere at vide

STEMCELL Technologies BSI-201

Artikelnummer. 17130332
Encompass_Preferred
Skift visning
Klik for at se tilgængelige muligheder
Mængde:
50 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Artikelnummer. Mængde
17130332 50 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Denne vare kan ikke returneres. Se returpolicy
Artikelnummer. 17130332 Leverandør STEMCELL Technologies Leverandørnr. 74122

Please to purchase this item. Need a web account? Register with us today!

This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.
Se alternative produkter

Denne vare kan ikke returneres. Se returpolicy

Cysteine-containing protein modifier; Inhibits growth of triple-negative breast cancer cells

  • BSI-201, also known as iniparib, can interact with the zinc finger domain of poly(ADP-ribose) polymerase 1 (PARP1) in vitro, but fails to inhibit the enzyme (Patel et al.) The nitroso metabolite of BSI-201 is highly reactive and forms non-specific covalent interactions with many cysteine-containing proteins (Liu et al.) BSI-201 has demonstrated anti-proliferative effects in triple-negative breast cancer cells (Chuang et al.; Yin et al.), and early studies indicated that it may be useful in treating early-stage triple-negative and BRCA1/2 mutation-associated breast cancer (O'Shaughnessy et al. 2009); however, its efficacy was later found to be insignificant (O'Shaughnessy et al.) 2014)

Tekniske data

CAS 160003-66-7
Synonym Iniparib; IND 71677
Mængde 50 mg
Molekylær formel C7H5IN2O3
Renhed ≥98%
Produkttitel
Vælg et problem

Ved at klikke på Send, anerkender du, at du kan blive kontaktet af Fisher Scientific med hensyn til den feedback, du har givet i denne formular. Vi deler ikke dine oplysninger til andre formål. Alle angivne kontaktoplysninger skal også vedligeholdes i overensstemmelse med vores Privatlivspolitik.